Treace Medical Concepts I...
8.00
-0.36 (-4.31%)
At close: Jan 14, 2025, 3:59 PM
8.01
0.12%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 6.52
Market Cap 498.38M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.99
PE Ratio (ttm) -8.08
Forward PE n/a
Analyst Hold
Ask 8.8
Volume 419,505
Avg. Volume (20D) 489,575
Open 8.45
Previous Close 8.36
Day's Range 7.74 - 8.57
52-Week Range 3.92 - 15.98
Beta undefined

About TMCI

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers pro...

Sector Healthcare
IPO Date Apr 23, 2021
Employees 516
Stock Exchange NASDAQ
Ticker Symbol TMCI

Analyst Forecast

According to 7 analyst ratings, the average rating for TMCI stock is "Hold." The 12-month stock price forecast is $8, which is a decrease of 0.00% from the latest price.

Buy 14.29%
Hold 85.71%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Treace Medical Concepts Inc. is scheduled to release its earnings on Feb 27, 2025, after market closes.
Analysts project revenue of $67.01M, reflecting a 7.71% YoY growth and earnings per share of -0.02, making a -80.00% decrease YoY.
2 days ago · Source
+14.52%
Treace Medical Concepts shares are trading higher ... Unlock content with Pro Subscription
2 weeks ago · Source
+8.14%
Treace Medical Concepts shares are trading higher after Lake Street initiated coverage on the stock with a Buy rating and announced a price target of $14.5.